CEBR member Biovia and BioWin, the health clusters of Flanders and Wallonia, invite the life sciences community to Science for Health 2026 on 10 November at SQUARE Brussels. Held in collaboration with Johnson & Johnson, this year’s edition focuses on “Immunology re-engineered: A new platform for precision medicine”.
Immunology as a platform for next-generation therapies
The event explores how advances in immunology are opening new routes for precision treatments, from cell and gene therapies and antibody engineering to immune modulation and targeted immunotherapies. Discussions will cover applications in oncology, infectious diseases and chronic inflammation, with a special focus on rare and complex diseases.
What to expect
Science for Health brings together academia, industry, PhD students and Belgium’s health innovation ecosystem to create new research connections. The programme combines:
- Expert talks and case studies on the latest developments in immunology
- Networking and one-to-one partnering between researchers and companies
- A PhD poster showcase highlighting the next generation of researchers
The event is supported by Belgium’s leading universities and research institutes as Knowledge Partners, including KU Leuven, Ghent University, imec, VIB, UCLouvain and ULB, among others.
A sell-out event
Every previous edition of Science for Health has sold out, with more than 300 participants. If you plan to attend, register early!



